abbvie-stock-slips-after-earnings,-charge-for-potential-opioid-deal

AbbVie Stock Slips After Earnings, Charge for Potential Opioid Deal

AbbVie Stock Slips After Earnings, Charge for Potential Opioid Deal

The drugmaker AbbVie turned in quarterly earnings that were roughly in line with Wall Street expectations, confirming financial forecasts it had issued earlier and disclosing a “potential settlement” of litigation over a business unit’s past sales of opioid drugs.

An error has occurred, please try again later.

 » Read More  » Read More

Tags: No tags

Comments are closed.